RxDoctor Payments Data

Theodore Wolfson, MD

Orthopaedic Surgery · Danbury, CTNPI 1639580665

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (40.7%), consulting fees and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Stryker at 37.6% of the total. Reporting peaked in 2019 at $37,452 and has fallen 63.0% since, to $13,846 in 2025. Among orthopaedic surgery clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$86,044in general payments, 2019–2025

Across 169 payments — averaging $509.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$32K
  • Arthrex$23K
  • Acumed LLC$15K
  • Smith+Nephew$12K
  • Encore Medical, LP$2K
  • Medwest Associates$1K
  • plus $1K from 13 others

What the payments were for

  • Consulting fees$23,70028%
  • Grants$35,00041%
  • Travel & lodging$7,9219%
  • Food & beverage$6,8508%
  • Education$12,57315%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$86,044 in reported general payments places this provider in the 90th percentile of 273 orthopaedic surgery providers in Connecticut.

See all orthopaedic surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$274,381
Medicare patients
421
Services billed
19,445

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefadroxil11$407
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen47$307
Tramadol Hcl72$223
Gabapentin31$202
Ibuprofen58$198
Methylprednisolone27$192
Meloxicam86$175
Methocarbamol18$125
Prednisone49$106
Mupirocin15$97
Ondansetron Hcl24$74
Amoxicillin14$18

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Danbury

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →